What are the Key Drivers of Reimbursement for Biosimilars? An Examination of Reimbursement Processes and Recommendations Across Nine Countries

Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.003
https://www.valueinhealthjournal.com/article/S1098-3015(13)01908-6/fulltext
Title : What are the Key Drivers of Reimbursement for Biosimilars? An Examination of Reimbursement Processes and Recommendations Across Nine Countries
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01908-6&doi=10.1016/j.jval.2013.08.003
First page : A323
Section Title : Health Care Expenditure or Reimbursement Studies – Biologics
Open access? : No
Section Order : 5
Categories :
Tags :
Regions :
ViH Article Tags :